Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 08:15:24 +0200Thu, 06 Jun 2024 15:00:00 +0200Myocet liposomal : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-297-en.pdfMyocet liposomal : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-297-en.pdfThu, 06 Jun 2024 15:00:00 +0200Human medicineHuman medicines European public assessment report (EPAR): Myocet liposomal (previously Myocet), doxorubicin, Date of authorisation: 13/07/2000, Revision: 25, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/myocet-liposomal-previously-myocetHuman medicines European public assessment report (EPAR): Myocet liposomal (previously Myocet), doxorubicin, Date of authorisation: 13/07/2000, Revision: 25, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/myocet-liposomal-previously-myocetThu, 06 Jun 2024 09:17:07 +0200Human medicine